State health inspectors identified the medical errors during an unannounced inspection in July 2018. In one situation, a 41-year-old woman chose to have a hysterectomy after incorrect pathology results led her to believe she had cancer. In another case, physicians told a 66-year-old patient his lab results were normal when a malignancy existed, according to a state inspection report cited by The Middletown Press.
CMS prohibited Bridgeport Hospital from performing cytology testing and stopped reimbursing the facility for the testing, effective Nov. 29, 2018. The hospital now outsources all cytology testing to Yale New Haven (Conn.) Hospital. Bridgeport Hospital must secure CMS’ approval before resuming any in-house cytology testing.
“Even in the best organizations, medical errors occur. When they do, our obligation is to acknowledge them, learn from them and ensure that we minimize any chance that they ever occur again,” Dana Marnane, director of communications for Yale New Haven Health, told The Middletown Press. “We took the results of the investigation very seriously and made changes to significantly improve our lab processes. We offered our heartfelt apologies and have pledged to do better in the future.”
More articles on clinical leadership and infection control:
Viewpoint: Antibiotic resistance should not make us feel helpless
Trends in nurse leaders’ salary and compensation: 5 report findings
Florida practice contacts police after mom films daughter licking medical supplies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.